Literature DB >> 29419427

A defined culture method enabling the establishment of ring sideroblasts from induced pluripotent cells of X-linked sideroblastic anemia.

Shunsuke Hatta1,2, Tohru Fujiwara1, Takako Yamamoto2, Kei Saito1, Mayumi Kamata1, Yoshiko Tamai3, Shin Kawamata2, Hideo Harigae4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29419427      PMCID： PMC5927992          DOI： 10.3324/haematol.2017.179770

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

Review 1.  Sideroblastic anemia: diagnosis and management.

Authors:  Sylvia S Bottomley; Mark D Fleming
Journal:  Hematol Oncol Clin North Am       Date:  2014-06-02       Impact factor: 3.722

2.  An Lysophosphatidic Acid Receptors 1 and 3 Axis Governs Cellular Senescence of Mesenchymal Stromal Cells and Promotes Growth and Vascularization of Multiple Myeloma.

Authors:  Masahiko Kanehira; Tohru Fujiwara; Shinji Nakajima; Yoko Okitsu; Yasushi Onishi; Noriko Fukuhara; Ryo Ichinohasama; Yoshinori Okada; Hideo Harigae
Journal:  Stem Cells       Date:  2016-09-29       Impact factor: 6.277

3.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

4.  Induced pluripotent stem cells with a mitochondrial DNA deletion.

Authors:  Anne B C Cherry; Katelyn E Gagne; Erin M McLoughlin; Anna Baccei; Bryan Gorman; Odelya Hartung; Justine D Miller; Jin Zhang; Rebecca L Zon; Tan A Ince; Ellis J Neufeld; Paul H Lerou; Mark D Fleming; George Q Daley; Suneet Agarwal
Journal:  Stem Cells       Date:  2013-07       Impact factor: 6.277

5.  Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.

Authors:  Mario Cazzola; Luca Malcovati
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015

6.  Aberrant iron accumulation and oxidized status of erythroid-specific delta-aminolevulinate synthase (ALAS2)-deficient definitive erythroblasts.

Authors:  Hideo Harigae; Osamu Nakajima; Naruyoshi Suwabe; Hisayuki Yokoyama; Kazumichi Furuyama; Takeshi Sasaki; Mitsuo Kaku; Masayuki Yamamoto; Shigeru Sassa
Journal:  Blood       Date:  2002-10-03       Impact factor: 22.113

7.  Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia.

Authors:  Duane L Guernsey; Haiyan Jiang; Dean R Campagna; Susan C Evans; Meghan Ferguson; Mark D Kellogg; Mathieu Lachance; Makoto Matsuoka; Mathew Nightingale; Andrea Rideout; Louis Saint-Amant; Paul J Schmidt; Andrew Orr; Sylvia S Bottomley; Mark D Fleming; Mark Ludman; Sarah Dyack; Conrad V Fernandez; Mark E Samuels
Journal:  Nat Genet       Date:  2009-05-03       Impact factor: 38.330

8.  An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells.

Authors:  Keisuke Okita; Tatsuya Yamakawa; Yasuko Matsumura; Yoshiko Sato; Naoki Amano; Akira Watanabe; Naoki Goshima; Shinya Yamanaka
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

9.  A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors.

Authors:  Akira Niwa; Toshio Heike; Katsutsugu Umeda; Koichi Oshima; Itaru Kato; Hiromi Sakai; Hirofumi Suemori; Tatsutoshi Nakahata; Megumu K Saito
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

10.  Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS).

Authors:  Rie Ohba; Kazumichi Furuyama; Kenichi Yoshida; Tohru Fujiwara; Noriko Fukuhara; Yasushi Onishi; Atsushi Manabe; Etsuro Ito; Keiya Ozawa; Seiji Kojima; Seishi Ogawa; Hideo Harigae
Journal:  Ann Hematol       Date:  2012-09-16       Impact factor: 3.673
View more
  5 in total

1.  Generation and Molecular Characterization of Human Ring Sideroblasts: a Key Role of Ferrous Iron in Terminal Erythroid Differentiation and Ring Sideroblast Formation.

Authors:  Kei Saito; Tohru Fujiwara; Shunsuke Hatta; Masanobu Morita; Koya Ono; Chie Suzuki; Noriko Fukuhara; Yasushi Onishi; Yukio Nakamura; Shin Kawamata; Ritsuko Shimizu; Masayuki Yamamoto; Hideo Harigae
Journal:  Mol Cell Biol       Date:  2019-03-19       Impact factor: 4.272

2.  Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome.

Authors:  Courtnee A Clough; Joseph Pangallo; Martina Sarchi; Janine O Ilagan; Khrystyna North; Rochelle Bergantinos; Massiel C Stolla; Jasmine Naru; Patrick Nugent; Eunhee Kim; Derek L Stirewalt; Arvind R Subramaniam; Omar Abdel-Wahab; Janis L Abkowitz; Robert K Bradley; Sergei Doulatov
Journal:  Blood       Date:  2022-03-31       Impact factor: 25.476

3.  Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis.

Authors:  Koya Ono; Tohru Fujiwara; Kei Saito; Hironari Nishizawa; Noriyuki Takahashi; Chie Suzuki; Tetsuro Ochi; Hiroki Kato; Yusho Ishii; Koichi Onodera; Satoshi Ichikawa; Noriko Fukuhara; Yasushi Onishi; Hisayuki Yokoyama; Rie Yamada; Yukio Nakamura; Kazuhiko Igarashi; Hideo Harigae
Journal:  Sci Rep       Date:  2022-05-30       Impact factor: 4.996

4.  Azacitidine is a potential therapeutic drug for pyridoxine-refractory female X-linked sideroblastic anemia.

Authors:  Yuki Morimoto; Kazuhisa Chonabayashi; Hiroshi Kawabata; Chikako Okubo; Makiko Yamasaki-Morita; Misato Nishikawa; Megumi Narita; Azusa Inagaki; Kayoko Nakanishi; Miki Nagao; Akifumi Takaori-Kondo; Yoshinori Yoshida
Journal:  Blood Adv       Date:  2022-02-22

5.  Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome.

Authors:  Tetsuro Ochi; Tohru Fujiwara; Koya Ono; Chie Suzuki; Maika Nikaido; Daichi Inoue; Hiroki Kato; Koichi Onodera; Satoshi Ichikawa; Noriko Fukuhara; Yasushi Onishi; Hisayuki Yokoyama; Yukio Nakamura; Hideo Harigae
Journal:  Sci Rep       Date:  2022-08-26       Impact factor: 4.996
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.